Selective COX-2 inhibition affects fatty acids, but not COX mRNA expression in patients with FAP

Familial adenomatous polyposis (FAP) provides a model for sporadic colorectal cancer development. Cyclooxygenase (COX) inhibition may ameliorate polyp development, but rofecoxib was withdrawn due to cardiovascular side effects. Although this selective COX-2 inhibitor, like diet, may alter the fatty...

Descripción completa

Detalles Bibliográficos
Autores principales: Almendingen, Kari, Larsen, Laila N., Fausa, Olav, Bratlie, Jorunn, Høstmark, Arne T., Aabakken, Lars
Formato: Texto
Lenguaje:English
Publicado: Springer Netherlands 2010
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2980621/
https://www.ncbi.nlm.nih.gov/pubmed/20593240
http://dx.doi.org/10.1007/s10689-010-9365-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2980621/
https://www.ncbi.nlm.nih.gov/pubmed/20593240
http://dx.doi.org/10.1007/s10689-010-9365-2

Ejemplares similares